Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) and antiphospholipid syndrome have an increased risk to develop cognitive impairment. A possible role for antiphospholipid antibodies (aPL) and antiglutamate receptor (anti-NMDA) antibodies in the pathogenesis of neurological manifestations of these two conditions,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Gerosa, Maria, Poletti, Barbara, Pregnolato, Francesca, Castellino, Gabriella, Lafronza, Annalisa, Silani, Vincenzo, Riboldi, Piersandro, Meroni, Pier Luigi, Merrill, Joan T.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740786/
https://ncbi.nlm.nih.gov/pubmed/26870034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars